U.S. General Merchandise and Department Stores Stock News

Marqeta (MQ) stock is in focus after the company announced on August 25, 2026, that Eugenia Gibbons will become Chief Product Officer. This may signal a potential shift in product priorities and execution. Marqeta shares trade at US$16.21 and recent moves have been mixed, with a 7 day share price return of 2.59% but a 30 day share price return that is down 10.29%. These shorter term swings sit against a 1 year total shareholder return that has declined 36.38% and a 5 year total shareholder...

RUM Group (RUM) recently disclosed a six year, roughly US$13.70b commercial agreement for GPU services tied to its planned Maysville, Georgia facility, with customer warrants linking future equity issuance to AI infrastructure usage. RUM Group's latest share price of US$9.43 comes after strong short term momentum, with a 30 day share price return of 56.38% and a year to date share price return of 48.04%. However, the 1 year total shareholder return of 27.09% and 5 year total shareholder...

Long term bond yields are pushing to decade highs, inflation is sitting at 3.4% against a 2% Fed target, and a new Fed chair who avoids clear forward guidance is keeping markets on edge. That mix can punish some stocks while opening different types of opportunities for others. This article explains how that backdrop relates to three U.S. insurance and annuity providers that may be especially exposed to the news. The stocks covered below are only a sample, and the full screen surfaced 20 more...

Oshkosh earnings beat and guidance reset Oshkosh (OSK) recently reported second quarter 2026 adjusted earnings that topped analyst expectations despite a year over year decline, while raising its full year sales outlook and trimming earnings guidance on slower fire truck production. Against this backdrop, Oshkosh’s share price has risen 20.55% over the past 90 days and 18.52% year to date to US$156.71, while the 1 year total shareholder return of 11.18% and 3 year total shareholder return of...

Veeco Instruments (VECO) has drawn fresh interest after recent trading data showed a 1 day gain of 1.7% and a year to date return of 53.7%. This performance has put its semiconductor exposure back in focus. At a latest share price of $46.95, Veeco Instruments has seen momentum cool in recent months, with the share price down 18.6% over the past 90 days. However, the year-to-date share price return of 53.7% and 1-year total shareholder return of 88.5% still point to a strong overall run that...

Accenture (ACN) recently agreed to acquire Japanese technology services provider COMWARE, adding more than 180 professionals to support Accenture Edge, its mid market focused business serving companies with AI, data, and cloud solutions. The COMWARE deal comes as Accenture’s share price has rallied recently, with a 1 month share price return of 13.8% and a 7 day share price return of 3.3% taking the stock to US$187.38. However, the year to date share price return is still down 27.9% and the 1...

Main Street Capital (MAIN) has drawn fresh attention after confirming another quarterly supplemental dividend of $0.30 per share in 2026, along with its monthly payouts, and signaling plans for an additional significant supplemental dividend in December. Recent dividend news comes after a strong 90-day share price return of 14.41% to US$58.59, even though the year to date share price return is down 5.12%. Over a longer stretch, Main Street Capital’s 3-year total shareholder return of 84.61%...

Earlier this week, AMC Entertainment Holdings said it is edging closer to sustained positive free cash flow, estimating it needs an industrywide domestic box office of about US$10.40 billion to reach that goal, helped by record adjusted EBITDA, stronger per-patron profitability, and lower interest costs. An important angle is that AMC’s recent refinancing and debt-repayment efforts are expected to cut annual cash interest expense, meaning the box-office level required to support ongoing...

MBX Biosciences (MBX) has reached a key clinical milestone with the first patient now dosed in its pivotal global Phase 3 oPTimize trial of once-weekly canvuparatide for chronic hypoparathyroidism. This step anchors current investor attention. For context, MBX Biosciences shares now trade at US$66.39, with a 30-day share price return of 10.54% and a 90-day share price return of 110.96%. The 1-year total shareholder return of 365.24% points to strong momentum as this Phase 3 trial gets...

With Canada preparing 15% to 50% retaliatory tariffs on U.S. goods and Arizona’s US$676 million export link to Canadian buyers under pressure, the fresh produce trade now sits at the crossroads of politics and profit. For investors, that creates potential mispricing as the market weighs tariff risk against long term demand for foodservice and distribution. This article walks through 3 stocks exposed to this news and explains why they may warrant closer attention before Sept. 8. The stocks...

On 24 August 2026, Tempus AI received FDA 510(k) clearance for Tempus ECG-PH, an AI tool that analyzes standard 12-lead ECGs for signs associated with pulmonary hypertension in symptomatic patients over 40 without a known history of the disease. This third FDA-cleared cardiovascular device extends Tempus AI’s AI-enabled diagnostics portfolio into pulmonary hypertension, a hard-to-diagnose condition affecting a meaningful share of older adults. We’ll now examine how this new FDA-cleared...

NPK International (NPKI) recently completed its rebranding from Newpark Resources Inc. The stock now reflects a clearer focus on temporary worksite access solutions that span power transmission, energy, and broader infrastructure services. NPK International’s share price has seen mixed momentum in recent months, with a 1-day share price return of 2.81% and a 30-day share price return of 4.71%, while the 90-day share price return is down 6.68%. At the same time, the stock’s longer history...

The Morning Bull - US Market Morning Update Friday, Aug, 28 2026 US Market stock futures are pointing higher this morning, with E-mini S&P 500 contracts up about 0.5% and Nasdaq-100 futures gaining more than 1%. The move comes after US durable goods orders rose 1.1% in July, which suggests companies are still spending on big ticket items like planes and machinery. At the same time, the PCE price index, a key inflation gauge watched by the Federal Reserve, increased 0.2% in July and is running...

Innodata has delivered very strong share price gains over the past five years, yet current valuation checks point to a stock that screens as expensive rather than a clear bargain. After such a long run, investors now have to weigh those historic returns against what the current price implies for the next leg of the story. Innodata has returned about 6.3x over 5 years, which puts extra focus on whether the current price already embeds very optimistic expectations. Recent leadership changes...

Alcoa Corporation recently held a groundbreaking ceremony for a new gallium production plant at its Wagerup alumina refinery in Western Australia, a project backed by government and industry partners from Australia, Japan and the United States and expected to support both construction and ongoing local jobs. The project’s focus on gallium, a critical mineral used in high-tech applications, underlines Alcoa’s expanding role in critical mineral supply chains alongside its core aluminum...

How Old National Bancorp Stock Has Been Trading Old National Bancorp (ONB) has drawn attention after a mixed stretch of recent returns. The stock is up slightly over the past week, roughly flat over the month, and higher over the past 3 months and year to date. At a share price of US$25.85, Old National Bancorp has delivered a 14.63% year to date share price return. Its 1 year total shareholder return of 16.35% and 3 year total shareholder return of 83.05% point to momentum that has built...

Earlier this week, UBS upgraded Fluence Energy’s stock rating from Sell to Neutral, signaling a shift in analyst stance despite the company’s continued loss-making and cash-burning profile. This change in sentiment stands out because it comes even as Fluence Energy’s negative EPS and constrained access to capital remain key concerns for cautious investors. We’ll now examine how UBS’s shift to a Neutral rating influences Fluence Energy’s investment narrative, particularly around risk...

Rockwell Automation recently launched TechConnectIQ Support, a 24x7 remote support offering for North American single-site contract customers, featuring AI-enabled tools, three-tier coverage, and improved visibility through the myRockwellAutomation TechConnect hub. The move highlights how Rockwell is aiming to deepen customer relationships by shifting more of its automation expertise into always-available, digitally delivered services. Next, we’ll explore how this enhanced remote support and...

Manhattan Associates (MANH) has drawn fresh attention after reporting better than expected second quarter 2026 earnings and revenue, and raising full year guidance for total and cloud revenue, which gives investors new information to assess the stock. The recent earnings surprise sits alongside strong share price momentum for Manhattan Associates, with a 90 day share price return of 49.12% and a 30 day share price return of 33.06%, while the 1 year total shareholder return of 2.43% shows much...

Morningstar and its subsidiary PitchBook previously announced upcoming Model Context Protocol integrations with Google Cloud’s Gemini Enterprise for Financial Services, bringing their public and private market intelligence directly into Gemini’s AI-powered workflows for eligible institutional users. The move effectively embeds Morningstar and PitchBook as core, source-attributed data and research providers inside Gemini Enterprise, potentially reshaping how professionals conduct investment...

Sarepta Therapeutics (SRPT) is back in focus after investors reacted to expectations for late 2026 clinical data in facioscapulohumeral muscular dystrophy and myotonic dystrophy, alongside developments in its Duchenne therapy Elevidys and a competitor setback. Sarepta Therapeutics' recent 1 day share price return of 10.95% and 30 day share price return of 39.92% suggest momentum has picked up as traders react to the Elevidys update and reduced competition. However, the 3 year total...

Moog (MOG.A) is in focus after opening its Advanced Integrated Manufacturing facility in Western New York. The $150 million project coincides with upward revisions to the company’s near term earnings estimates. Against this backdrop, Moog’s share price has been volatile in the short term, with a 30 day share price return down 7.6%. At the same time, the year to date share price return is 53.4%, and the 5 year total shareholder return is 404.6%. This pattern suggests that momentum has been...

AT&T (T) is in focus after Hark announced a partnership that pairs AT&T’s network infrastructure with Hark’s AI-native consumer devices, connecting hardware directly to AI without relying on phones or Wi-Fi. Against this backdrop, AT&T’s 30 day share price return of 3.12% and 90 day share price return of 2.54% suggest modest positive momentum, while the 3 year total shareholder return of 101.35% sits in sharp contrast to the 1 year total shareholder return, which declined 7.99%. This...

Earlier this week, Zacks highlighted Horace Mann Educators Corporation (HMN) as a top value and income stock, citing its Rank #1 (Strong Buy) rating, 6.2% rise in current-year earnings estimates over the past 60 days, and a price-to-earnings ratio below the broader insurance industry. HMN’s inclusion on both Zacks’ value and income stock lists, supported by a dividend yield above the industry average, underscores growing analyst confidence in the company’s earnings and income profile. Next,...